20 Patents
- 0 cites
- US125347442026Methods to Genetically Modify Cells for Delivery of Therapeutic Proteins
CELLECTIS S.A.
0 cites - 0 cites
- 0 cites
- 0 cites
- US122214782025Targeted Gene Integration of CRS Inhibitor Genes for Improved Immune Cells Therapy
CELLECTIS
0 cites - US122091252025Targeted Gene Integration of NK Inhibitors Genes for Improved Immune Cells Therapy
CELLECTIS
0 cites - 0 cites
- US119590912024Methods for Engineering T Cells for Immunotherapy by Using Rna-guided Cas Nuclease System
Cellectis
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- US117675122023Sequence Specific Reagents Targeting CCR5 in Primary Hematopoietic Cells
ALBERT-LUDWIGS-UNIVERSITAT FREIBURG
0 cites - 0 cites
- US116921692023Cells for Immunotherapy Engineered for Targeting Antigen Present Both on Immune Cells and Pathological Cells
CELLECTIS
0 cites - 0 cites
- 0 cites